The One Health Company is the first to bring the latest advances in human oncology - individualized, precision medicine - to dogs with cancer. The firm is a mission company that delivers the most sophisticated diagnostics and create a tailored treatment plan for each dog. The firm's flagship product, FidoCure, leverages what has been approved for human use, with additional data specific to canine cancer.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 11/04/20 | $10,000,000 |
Borealis Ventures Lerer Hippeau Ventures Polaris Partners Tau Ventures Y Combinator | undisclosed |
